⚠️ This provider averages 753 services per working day — physically unusual for an individual practitioner
Based on 1.9M total services over 10 years (250 working days/year). Learn about impossible service volumes →
This provider's $28.4M in total Medicare payments ranks in the 99th percentile of Rheumatology providers nationally.
Averaging 753 services per working day raises questions about billing patterns.
Medicare payments to this provider grew 175% from 2014 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 53% in 2016
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $26.53 | $9.24 | 2.87x | $17.29 | $1.2M | 124.6K | 23 |
| 2015 | $27.79 | $10.80 | 2.57x | $16.99 | $1.6M | 145.7K | 24 |
| 2016 | $32.55 | $14.59 | 2.23x | $17.96 | $2.4M | 164.8K | 25 |
| 2017 | $38.74 | $16.79 | 2.31x | $21.95 | $2.5M | 150.0K | 25 |
| 2018 | $40.90 | $17.26 | 2.37x | $23.64 | $3.4M | 194.9K | 27 |
| 2019 | $31.14 | $13.50 | 2.31x | $17.64 | $3.3M | 241.0K | 24 |
| 2020 | $32.74 | $15.01 | 2.18x | $17.73 | $4.0M | 265.9K | 26 |
| 2021 | $39.45 | $17.34 | 2.28x | $22.11 | $3.9M | 224.1K | 21 |
| 2022 | $42.77 | $16.47 | 2.60x | $26.30 | $3.1M | 186.2K | 21 |
| 2023 | $44.71 | $17.09 | 2.62x | $27.62 | $3.2M | 185.5K | 27 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 302.0K | $11.4M | $37.86 | 1.87x |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 90.5K | $4.6M | $50.53 | 2.47x |
| J3262 | Injection, tocilizumab, 1 mg | 1.2M | $4.5M | $3.78 | 3.17x |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 24.7K | $2.1M | $84.16 | 2.13x |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 10.2K | $1.1M | $106.68 | 2.62x |
| J0897 | Injection, denosumab, 1 mg | 53.1K | $822.5K | $15.49 | 3.23x |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 46.7K | $592.8K | $12.69 | 2.76x |
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 16.5K | $470.0K | $28.56 | 3.85x |
| J9310 | Injection, rituximab, 100 mg | 662 | $431.6K | $651.97 | 1.37x |
| J2357 | Injection, omalizumab, 5 mg | 10.4K | $314.2K | $30.27 | 1.82x |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | 1.9K | $294.8K | $152.91 | 2.70x |
| 96415 | Administration of chemotherapy into vein, each additional hour | 12.5K | $286.6K | $22.90 | 3.27x |
| J9312 | Injection, rituximab, 10 mg | 3.5K | $260.2K | $74.34 | 1.35x |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | 6.1K | $245.0K | $39.99 | 3.16x |
| 96375 | Injection of additional new drug or substance into vein | 17.6K | $244.5K | $13.85 | 3.25x |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 1.9K | $114.0K | $59.34 | 2.51x |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 13.2K | $96.7K | $7.31 | 2.94x |
| 36415 | Insertion of needle into vein for collection of blood sample | 24.5K | $85.7K | $3.49 | 4.29x |
| 20610 | Aspiration and/or injection of fluid from large joint | 1.9K | $83.2K | $43.69 | 5.15x |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 1.2K | $68.4K | $57.93 | 2.45x |
This provider submits charges 2.39 times higher than what Medicare actually pays.
A markup ratio of 2.39x means for every $100 Medicare pays, this provider initially charges $239. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Rheumatology providers in FL for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Aymen Kenawy, M.D. | Lynn Haven, FL | $56.3M | ✓ Clear |
| Vipul Joshi, MD | Brandon, FL | $41.8M | ✓ Clear |
| Adam Rosen, MD | Clearwater, FL | $38.6M | ✓ Clear |
| Eugenia Rullan Bidot, MD | Clearwater, FL | $38.2M | ✓ Clear |
| Marc Hirsh, M.D. | Delray Beach, FL | $33.8M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data